Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

CABA Cabaletta Bio Inc

1,80

-0,05 (-2,70%)

11 Mär 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Cabaletta Bio Charts.

Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Cabaletta Bio Charts.

News Cabaletta Bio Inc

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 März 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 März 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 März 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 März 2025 (6 Tage vor) • Edgar (US Regulatory)

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
Mittwoch 26 Februar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Dienstag 18 Februar 2025 (3 Wochen vor) • Edgar (US Regulatory)

UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
Dienstag 18 Februar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 18 Februar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
Dienstag 18 Februar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
Dienstag 11 Februar 2025 (4 Wochen vor) • GlobeNewswire Inc.

Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
Mittwoch 29 Januar 2025 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 13 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Weitere Cabaletta Bio Inc News-Artikel

Petrobas Global Finance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen